Betaherpesviruses in transplant recipients

Area of Science:

• Virology
• Transplantation Immunology
• Infectious Diseases

Background:

• Betaherpesviruses, including cytomegalovirus (CMV) and human herpesviruses 6 and 7 (HHV-6, HHV-7), are known human pathogens.
• These viruses can cause opportunistic infections in immunocompromised individuals, particularly after organ transplantation.

Purpose of the Study:

• To investigate the clinical significance of betaherpesviruses, specifically CMV, HHV-6, and HHV-7, in the context of organ transplantation.
• To determine the association between viral load and the development of CMV disease and allograft rejection.

Main Methods:

• Quantitative analysis of viral loads for CMV, HHV-6, and HHV-7 in transplant recipients.
• Correlation of viral loads with clinical outcomes, including end-organ disease and biopsy-proven graft rejection.

Main Results:

• Patients with overt CMV disease exhibit significantly higher CMV viral loads compared to asymptomatic individuals.
• High CMV viral load is a major determinant of risk factors for CMV disease, such as pre-transplant serostatus and post-transplant viremia.
• CMV is implicated in allograft rejection, which can be mitigated by antiviral prophylaxis.
• Quantitative studies reveal that HHV-6 and CMV are independently associated with graft rejection after liver transplantation.

Conclusions:

• The clinical significance of betaherpesviruses in transplantation may be underestimated.
• Viral load quantification is crucial for understanding the pathogenesis of CMV disease and its complications.
• HHV-6 and CMV are significant contributors to graft rejection in liver transplant recipients.